Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy
Blood and Lymphatic Cancer: Targets and Therapy
Editor-in-Chief: Dr Wilson Gonsalves
An international, peer reviewed, open access journal focusing on blood and lymphatic cancer research, identification of therapeutic targets, and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for the cancer patient.
The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, case reports, and extended reports.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (140)
- Volume 16, 2026 (14)
- Volume 15, 2025 (19)
- Volume 14, 2024 (6)
- Volume 13, 2023 (7)
- Volume 12, 2022 (12)
- Volume 11, 2021 (6)
- Volume 10, 2020 (2)
- Volume 9, 2019 (7)
- Volume 8, 2018 (7)
- Volume 7, 2017 (8)
- Volume 6, 2016 (5)
- Volume 5, 2015 (11)
- Volume 4, 2014 (13)
- Volume 3, 2013 (6)
- Volume 2, 2012 (12)
- Volume 1, 2011 (5)
Latest articles:
- 5 records -
Short-Term Longitudinal Analysis of Gut Microbiota Dynamics During Anti-CD19 CAR-T Cell Therapy in Diffuse Large B-Cell Lymphoma Patients
Shen Z, Xing X, Rong K, Geng Z, Yang N, Xu L, Ge H, Sang W
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:598958
Published Date: 1 May 2026
Poor Outcome of Pediatric Patients with Acute Lymphoblastic Leukemia Harboring Low P16 Deletion Ratio: A Post-Hoc Analysis from a Prospective Cohort
Qiu KY, Liao XY, Chen HL, Zheng H, Fang JP, Zhou DH
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:592290
Published Date: 30 April 2026
Defining High-Risk Disease Biology in Multiple Myeloma: A Narrative Review
Aljumaa M, Hamam Refai H, Chawla Y, Gonsalves WI
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:586948
Published Date: 27 April 2026
Enzymatic Laccase Nanoreactors Induce Apoptosis in MOLT-4-ALL Cells and Activate Prodrugs in a Synergetic Effect
Medrano-Villagómez CA, Loredo-García E, Gasperin-Bulbarela J, Vazquez-Duhalt R
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:576292
Published Date: 27 April 2026
Venetoclax Plus Hypomethylating Agents for Treatment-Naïve Myelodysplastic Syndromes with Increased Blasts: A Prospective Multicenter Cohort Study
Zhao N, Zhu L, Hu X, Tong J, Ge H, Ye L, Zhu X, Gai C, Feng Y, Zhang L, Wang L, Sun G, Xue L, Zhu X, Zheng C
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:592550
Published Date: 24 April 2026